Loading
Loading
Jazz Pharmaceuticals ceo salary
Renee D. Gala, President CEO and Director of Jazz Pharmaceuticals plc (JAZZ), received $19,151,558 ($19.2M) in total compensation for FY2025, up 23.3% from the prior year. Stock awards of $16,138,433 were the largest component. Figures come from Jazz Pharmaceuticals plc's DEF 14A filed 8 Jun 2026 (accession 0001232524-26-000029).
Reported total from the latest DEF 14A pay table. Source filing (accession 0001232524-26-000029). These figures come from Jazz Pharmaceuticals plc's DEF 14A filed 8 Jun 2026 (accession 0001232524-26-000029).
| Component | Amount |
|---|---|
| Salary | $1,003,269 |
| Stock awards | $16,138,433 |
| Cash incentive | $1,980,000 |
| Other | $29,856 |
| Total | $19,151,558 |
FAQ
See also: JAZZ ticker page